Imunon (NASDAQ: CLSN)
Imunon Return vs. S&P
| 1 Year | 5 Year | 5 Year Annualized | Since IPO |
|---|
Imunon Company Info
Imunon, Inc. is a clinical stage oncology drug company. It focuses on cancer treatments, including directed chemotherapies, DNA-mediated immunotherapy and RNA-based therapies. The firm is also engaged in the research and development of pharmaceutical products for cancer treatments. Its portfolio includes deoxyribonucleic acid-mediated immunotherapy and ribonucleic acid-based therapies. It operates through the Celsion and ThermoDox brands. The company was founded by Yim-Pan Cheung in 1982 and is headquartered in Lawrenceville, NJ.
News & Analysis
3 Biotech Stocks To Avoid
After a history of failures, these three biotech stocks are running out of ideas and cash to keep their operations going.
A Fool Looks Back
A lot of things happened this past week. Let's check it out.
The Fool Looks Ahead
It will be an interesting week if you know where to look.
This Week in Biotech
A look back at the biggest stories this week in biotech and what they mean for investors.
3 Horrendous Health-Care Stocks This Week
The Fool looks at 3 horrendous health-care stocks from the past week.
Why Celsion Shares Were Eviscerated
Is this meaningful or just another movement?
Why Shares of Celsion Got Crushed Today
What caused shares of this drugmaker to spiral today?
Celsion Collapses on Failure: What's Next?
HEAT trial failed. Shares down over 80%. Is there any hope?
Valuation
Related Stocks
Premium Investing Services
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.